Vericel Corp. (VCEL)
40.91
+0.41
(+1.01%)
USD |
NASDAQ |
Sep 02, 16:00
40.91
0.00 (0.00%)
After-Hours: 16:04
Vericel Research and Development Expense (Annual) : 27.56M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.56M |
| December 31, 2024 | 24.80M |
| December 31, 2023 | 21.04M |
| December 31, 2022 | 19.94M |
| December 31, 2021 | 16.29M |
| December 31, 2020 | 13.02M |
| December 31, 2019 | 30.39M |
| December 31, 2018 | 13.60M |
| December 31, 2017 | 12.94M |
| December 31, 2016 | 15.00M |
| December 31, 2015 | 18.89M |
| December 31, 2014 | 21.26M |
| December 31, 2013 | 15.10M |
| December 31, 2012 | 26.02M |
| December 31, 2011 | 21.33M |
| Date | Value |
|---|---|
| December 31, 2010 | 17.22M |
| June 30, 2009 | 11.29M |
| June 30, 2008 | 15.25M |
| June 30, 2007 | 11.44M |
| June 30, 2006 | 9.484M |
| June 30, 2005 | 7.206M |
| June 30, 2004 | 6.289M |
| June 30, 2003 | |
| June 30, 2002 | |
| June 30, 2001 | |
| June 30, 2000 | 6.289M |
| June 30, 1999 | 10.87M |
| June 30, 1998 | 15.50M |
| June 30, 1997 | 12.79M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AbbVie, Inc. | 8.249B |
| ADMA Biologics, Inc. | 4.762M |
| Kyntra Bio, Inc. | 23.52M |
| Conexeu Sciences, Inc. | 0.4782M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |